Myositis (Idiopathic Inflammatory Myopathy, IIM) are auto-immune diseases related to muscles. They are not hereditary. They are characterized by a muscle weakness and fatigability, and very often by muscle pain (myalgia).


Clinical trial on Inclusion Body Myositis ongoing at the Institute:

  • ABATACEPT : A Phase 3, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC with Standard Treatment Compared to Standard Treatment Alone in Improving Disease Activity in Adults with Active Idiopathic Inflammatory Myopathy (IIM)


Olivier Benveniste



Study type RBM
Trial type Multicentre trial
Intervention Abatacept / standard treatment / placebo
Principal investigator Olivier Benveniste
Role Investigator
Study status Ongoing
Recruitment status Ongoing
Population Adult
+ infos on